O'Connor R - Search Results

1

Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts.

Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF. Gottschalk M, et al. NMR Biomed. 2008 Oct;21(8):809-19. doi: 10.1002/nbm.1258. NMR Biomed. 2008. PMID: 18470962

2

Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.

Liang Y, O'Driscoll L, McDonnell S, Doolan P, Oglesby I, Duffy K, O'Connor R, Clynes M. Liang Y, et al. Int J Cancer. 2004 Sep 10;111(4):484-93. doi: 10.1002/ijc.20230. Int J Cancer. 2004. PMID: 15239124

3

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.

Collins DM, Crown J, O'Donovan N, Devery A, O'Sullivan F, O'Driscoll L, Clynes M, O'Connor R. Collins DM, et al. Invest New Drugs. 2010 Aug;28(4):433-44. doi: 10.1007/s10637-009-9266-0. Epub 2009 Jun 5. Invest New Drugs. 2010. PMID: 19499189

4

Modulation of P-gp expression by lapatinib.

Dunne G, Breen L, Collins DM, Roche S, Clynes M, O'Connor R. Dunne G, et al. Invest New Drugs. 2011 Dec;29(6):1284-93. doi: 10.1007/s10637-010-9482-7. Epub 2010 Jul 6. Invest New Drugs. 2011. PMID: 20607587

5

Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.

Brougham DF, Ivanova G, Gottschalk M, Collins DM, Eustace AJ, O'Connor R, Havel J. Brougham DF, et al. J Biomed Biotechnol. 2011;2011:158094. doi: 10.1155/2011/158094. Epub 2010 Sep 15. J Biomed Biotechnol. 2011. PMID: 20886062 Free PMC article.

6

Stable aqueous dispersions of glycopeptide-grafted selectably functionalized magnetic nanoparticles.

Borase T, Ninjbadgar T, Kapetanakis A, Roche S, O'Connor R, Kerskens C, Heise A, Brougham DF. Borase T, et al. Angew Chem Int Ed Engl. 2013 Mar 11;52(11):3164-7. doi: 10.1002/anie.201208099. Epub 2013 Feb 1. Angew Chem Int Ed Engl. 2013. PMID: 23371331 No abstract available.

7

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells.

Gaule P, Mukherjee N, Corkery B, Eustace AJ, Gately K, Roche S, O'Connor R, O'Byrne KJ, Walsh N, Duffy MJ, Crown J, O'Donovan N. Gaule P, et al. Cancers (Basel). 2019 Apr 17;11(4):548. doi: 10.3390/cancers11040548. Cancers (Basel). 2019. PMID: 30999598 Free PMC article.

8

Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

Duffy CP, Elliott CJ, O'Connor RA, Heenan MM, Coyle S, Cleary IM, Kavanagh K, Verhaegen S, O'Loughlin CM, NicAmhlaoibh R, Clynes M. Duffy CP, et al. Eur J Cancer. 1998 Jul;34(8):1250-9. doi: 10.1016/s0959-8049(98)00045-8. Eur J Cancer. 1998. PMID: 9849488

9

Increased anti-tumour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-positive human lung cancer.

O'Connor R, Heenan M, Connolly L, Larkin A, Clynes M. O'Connor R, et al. Anticancer Res. 2004 Mar-Apr;24(2A):457-64. Anticancer Res. 2004. PMID: 15152944 Free article.

10

Overexpression of cytochrome P450 NADPH reductase sensitises MDA 231 breast carcinoma cells to 5-fluorouracil: possible mechanisms involved.

Martinez VG, Williams KJ, Stratford IJ, Clynes M, O'Connor R. Martinez VG, et al. Toxicol In Vitro. 2008 Apr;22(3):582-8. doi: 10.1016/j.tiv.2007.11.017. Epub 2007 Dec 7. Toxicol In Vitro. 2008. PMID: 18191533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,279 results

Search Page

Filters